Three Questions
No, That New Study Doesn’t Show that Masks Are Useless
We asked Prof. Jason Abaluck, who co-authored a landmark randomized trial of mask promotion in Bangladesh, what conclusions we can draw from the recent Cochrane Review—and what the evidence says about the effectiveness of masks.
The Balloons Signal a New Age of Mass Surveillance
Prof. Paul Bracken, an expert in global competition and strategy, says these encounters reveal an urgent need for citizens and governments to catch up on how much we’re already being spied on.
Will the Backlash from the Right Slow ESG Investing?
A string of Republican-led states have pulled funds from firms that use environmental, social, and governance criteria in making investments. We asked Yale SOM’s Todd Cort what the political backlash means for the future of ESG investing.
The End of Noncompete Agreements May Be Near
Earlier this month, the Federal Trade Commission unveiled a proposal that would block companies from limiting their employees’ ability to work for a rival through noncompete agreements. We asked Yale SOM’s Fiona Scott Morton about the ban’s potential impact on wages, innovation, and the economy as a whole.
How to Give Better Gifts
Do your loved ones want their presents to be expensive or thoughtful? Do they want to be surprised or to get items from their wish lists? We asked Professor Nathan Novemsky, a psychologist and expert in consumer behavior, to explain some of the common mistakes that gift-givers make.
Did Ticketmaster’s Market Dominance Fuel the Chaos for Swifties?
Taylor Swift fans scrambling for concert tickets faced endless queues and crashes on the Ticketmaster website. Yale SOM economist Florian Ederer explains the antitrust issues at play and the tradeoffs inherent in satisfying overwhelming demand.
Will the Fed Keep Raising Rates?
We asked Prof. William English, a former Fed official, to interpret the announcements at the Federal Open Market Committee’s monthly meeting last week.
What’s the Future for Western Businesses in Xi’s China?
We asked Stephen Roach, a senior fellow at Yale Law School’s Paul Tsai China Center, what another five years of Xi Jinping’s leadership means for China’s economic policies and the environment for Western businesses there.
Could Russia Really Go Nuclear?
We asked Paul Bracken, an expert in nuclear strategy, how this “unthinkable” scenario would play out.
Can the Inflation Reduction Act Bring Down Drug Prices?
We asked Prof. Fiona Scott Morton, an expert on competition in the healthcare industry, whether the new legislation will make a difference—and what it will take to get drug prices under control.
